We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Volume 15, Issue 13 / September 2023

Plain Language Summary of PublicationOpen Access
May 2023
Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary
  • Pages:975–980
  • Published Online:31 May 2023
Drug Evaluation
July 2023
The role of lebrikizumab in the treatment of atopic dermatitis in the adult population
  • Pages:981–991
  • Published Online:4 July 2023
Case Report
July 2023
Successful treatment with carboplatin and paclitaxel in melanoma progression after immune-related adverse events
  • Pages:993–999
  • Published Online:31 July 2023
Case Report
July 2023
Immune-related gigantomastia: a case study
  • Pages:1001–1007
  • Published Online:11 July 2023
Case Report
July 2023
Prolonged clinical remission of type 1 diabetes sustained by calcifediol and low-dose basal insulin: a case report
  • Pages:1009–1019
  • Published Online:4 July 2023
Short Communication
June 2023
Enhanced binding at fever temperatures of HER2 in complex with trastuzumab and pertuzumab
  • Pages:1021–1027
  • Published Online:20 June 2023
Research ArticleOpen Access
July 2023
Pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer without tumor PD-L1 expression in Asia
  • Pages:1029–1044
  • Published Online:19 July 2023
Research Article
July 2023
Cost–effectiveness analysis of serplulimab as first-line treatment for advanced esophageal squamous cell carcinoma
  • Pages:1045–1055
  • Published Online:4 July 2023
Perspective
July 2023
The role of immune subtyping in glioma mRNA vaccine development
  • Pages:1057–1072
  • Published Online:11 July 2023
Meta-AnalysisOpen Access
June 2023
A meta-analysis of application of PD-1/PD-L1 inhibitor-based immunotherapy in unresectable locally advanced triple-negative breast cancer
  • Pages:1073–1088
  • Published Online:20 June 2023